96 results on '"Litvinov, Ivan V."'
Search Results
2. Immunosenescence, Inflammaging, and Dermatology: Insights and Opportunities
3. Informing a Canadian Skin Science Trainee Program Based on the State of Trainee Programs Offered by International Academic Societies
4. Utilization of the Psoriasis Epidemiology Screening Tool (PEST): A Risk Stratification Strategy for Early Referral of Psoriatic Arthritis Patients to Minimize Irreversible Erosive Joint Damage
5. Common Personal Care Products Contaminated With Benzene, a Known Human Carcinogen, Identified Recently
6. In Preparation for Biosimilar “Switch” Policy: How to Mitigate the Nocebo Effect
7. Reflex Molecular Testing in Melanoma Diagnosis: When Should BRAF Mutation Testing Be Ordered and Who Should Order It?
8. Benzene, a Known Human Carcinogen, Detected in Suncare Products
9. Prominent Role of Type 2 Immunity in Skin Diseases: Beyond Atopic Dermatitis
10. Delayed Cutaneous Reactivity Associated With COVID-19 Vaccines Is Rare
11. Inhibition of IL-13: A New Pathway for Atopic Dermatitis
12. Toward Understanding of Environmental Risk Factors in Systemic Sclerosis
13. Cutaneous Immune-Related Adverse Events (irAEs) to Immune Checkpoint Inhibitors: A Dermatology Perspective on Management
14. Preliminary Data Suggests That Biologics in Dermatology Are Not Associated With Adverse COVID-19 Outcomes
15. Newer and Safer Kappa-Opioid Agonist for Your Patients With Uremic Pruritus
16. SB206, a New Topical Nitric Oxide-Releasing Drug on the Horizon for the Treatment of Molluscum Contagiosum and External Anogenital Warts
17. The Novel Role of Antibiotic Treatment in the Management of Cutaneous T-Cell Lymphoma (CTCL) Patients
18. Cutaneous Manifestations of Coronavirus Disease 2019 (COVID-19) Infection—What Do We Know So Far?
19. The Need to Evaluate the Risks and Benefits Posed by Quebec Bill 43 Expanding Nurse Practitioners’ Scope of Practice
20. Dysregulations in Autoimmune Regulator (AIRE) in Controlling B and T Cell Tolerance Have Important Implications for a Broad Range of Dermatologic Diseases
21. Cytotoxic T Cells Are Replaced by Novel Clones After Immune Checkpoint Blocker Therapy
22. Epidemiology and Patient Distribution of Oral Cavity and Oropharyngeal SCC in Canada
23. Review of Evidence and Recommendation for Human Papillomavirus (HPV) Vaccination of Canadian Males Over the Age of 26 Years
24. Dietary Vitamin A Intake Is Shown to Decrease the Risk of Cutaneous Squamous Cell Carcinomas
25. Spesolimab: A Novel Treatment for Pustular Psoriasis
26. Treatment Modalities for Varicose Veins of Lower Extremities
27. The Future of Bullous Pemphigoid (BP): New and Promising Drugs May Revolutionize Treatment Course for BP Patients
28. Recent Advances in Evaluating Impact of Biologic Therapy for Moderate-Severe Psoriasis on Cardiovascular Events and Atherosclerotic Plaque Formation
29. The Need to Evaluate Risks and Benefits of Ontario Nurse Practitioners Performing Cosmetic Procedures Following Amendments to the Ontario Nursing Act 1991
30. Time to Change Guidelines for Laboratory Monitoring During Isotretinoin Treatment
31. Oral Minoxidil: A Possible New Therapy for Androgenetic Alopecia
32. Penile Invasive Squamous Cell Carcinoma: Analysis of Incidence, Mortality Trends, and Geographic Distribution in Canada
33. Annual Screening for Skin Cancers Should Be Implemented in High-Risk Allogeneic Hematopoietic Stem Cell Transplant Recipients
34. Hawaii and Other Jurisdictions Ban Oxybenzone or Octinoxate Sunscreens Based on the Confirmed Adverse Environmental Effects of Sunscreen Ingredients on Aquatic Environments
35. New dl5-29–Attenuated Replication-Deficient HSV Vaccine Provides a Ray of Hope for the Prevention of Neonatal HSV Infection
36. The Need to Evaluate Risks and Benefits of Pharmacists Independently Diagnosing and Treating Dermatologic Conditions in Canada
37. Recent Therapeutic Advances in Pruritus Management for Atopic Dermatitis Patients: A Welcome Addition of Asivatrep to Our Arsenal of Future Topical Treatments
38. Immunotherapy for Cutaneous T-Cell Lymphoma: Current Landscape and Future Developments
39. Fluorouracil is Superior to Other Commonly Used Topical Agents for the Treatment of Field Cancerization
40. Naltrexone for the Treatment of Darier and Hailey-Hailey Diseases
41. Systemic Absorption of Common Organic Sunscreen Ingredients Raises Possible Safety Concerns for Patients
42. Hidradenitis Suppurativa: Comprehensive Review of Predisposing Genetic Mutations and Changes
43. Incidence, Mortality, and Spatiotemporal Distribution of Cutaneous Malignant Melanoma Cases Across Canada
44. A Vision for an Academic Career Mentorship Program for Canadian Dermatology Residents
45. Distribution and Clustering of Cutaneous T-Cell Lymphoma (CTCL) Cases in Canada: A Response to a Letter
46. Distribution and Clustering of Cutaneous T-Cell Lymphoma (CTCL) Cases in Canada During 1992 to 2010
47. Differences in Photoprotective Behaviours Based on Immigration Status: A Systematic Review.
48. Cutaneous Melanoma Mortality-to-Incidence Ratio and Its Association With Socioeconomic and Healthcare Factors in Canada: A National Ecological Study.
49. Increased Risk of Keratinocyte Carcinomas, Merkel Cell Carcinoma, and Other Skin Cancers in Patients Treated With Janus Kinase 1 and 2 Inhibitor, Ruxolitinib.
50. The Role of Sex and Gender in Dermatology - From Pathogenesis to Clinical Implications.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.